JAC Advance Access originally published online on April 22, 2008
Journal of Antimicrobial Chemotherapy 2008 62(2):388-396; doi:10.1093/jac/dkn163
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original research |
A case–control study of community-associated Clostridium difficile infection
1 Department of Microbiology, Leeds Teaching Hospitals, Old Medical School, Leeds LS1 3EX, UK 2 University of Leeds, Leeds, UK 3 Department of Microbiology, Royal Cornwall Hospital, Truro, Cornwall, UK 4 Department of Microbiology, Sunderland Royal Hospital, Sunderland, UK
Received 23 January 2008; returned 19 February 2008; revised 5 March 2008; accepted 19 March 2008
* Correspondence address. Department of Microbiology, Old Medical School, Leeds General Infirmary and University of Leeds, Leeds LS1 3EX, UK. Tel: +44-113-3926818; Fax: +44-113-3435649; E-mail: mark.wilcox{at}leedsth.nhs.uk
Objectives: The aim of this study was to determine the incidence of and risk factors for community-associated Clostridium difficile infection (CDI).
Methods: Prospective surveillance of community-derived faecal samples for C. difficile cytotoxin, followed by a questionnaire-based case–control study in two distinct patient cohorts (one semi-rural and the other urban).
Results: The proportion of randomly selected faecal samples positive for C. difficile cytotoxin was 2.1% in both patient cohorts (median ages 73 and 45 years for the urban and semi-rural cohorts, respectively). Exposure to antibiotics in the previous 4 weeks, particularly multiple agents (P < 0.001), aminopenicillins (P < 0.05) and oral cephalosporins (P < 0.05), was significantly more frequent among cases than controls. Hospitalization in the preceding 6 months was significantly associated with CDI (45% versus 23%; P = 0.022). However, almost half the cases had not received antibiotic therapy in the month before C. difficile detection, and approximately one-third neither had exposure to antibiotics nor recent hospitalization. Contact with infants aged 
2 years was significantly associated with CDI (14% versus 2%; P = 0.02). Prior exposure to gastrointestinal-acting drugs (proton pump inhibitor, H2 antagonist or non-steroidal anti-inflammatory) was not significantly more common in CDI cases. C. difficile PCR ribotype 001 caused 60% and 13% of urban and semi-rural community-associated CDI cases, respectively.
Conclusions: Reliance on antibiotic history and age (
65 years) will contribute to missed diagnoses of community-associated CDI. Potential risk factors for community-associated CDI should be explored further to explain the large proportion of cases not linked to recent antibiotic therapy or hospitalization.
Keywords: antibiotics , diarrhoea , community-acquired
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. M. Nerandzic, M. J. Pultz, and C. J. Donskey Examination of Potential Mechanisms To Explain the Association between Proton Pump Inhibitors and Clostridium difficile Infection Antimicrob. Agents Chemother., October 1, 2009; 53(10): 4133 - 4137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Eastwood, P. Else, A. Charlett, and M. Wilcox Comparison of Nine Commercially Available Clostridium difficile Toxin Detection Assays, a Real-Time PCR Assay for C. difficile tcdB, and a Glutamate Dehydrogenase Detection Assay to Cytotoxin Testing and Cytotoxigenic Culture Methods J. Clin. Microbiol., October 1, 2009; 47(10): 3211 - 3217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. M. Limbago, C. M. Long, A. D. Thompson, G. E. Killgore, G. E. Hannett, N. L. Havill, S. Mickelson, S. Lathrop, T. F. Jones, M. M. Park, et al. Clostridium difficile Strains from Community-Associated Infections J. Clin. Microbiol., September 1, 2009; 47(9): 3004 - 3007. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Gouliouris, D. R. Forsyth, and N. M. Brown Clostridium difficile-associated diarrhoea (CDAD): new and contentious issues Age Ageing, September 1, 2009; 38(5): 497 - 500. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Elvy, T. Riordan, P. Sarsfield, and T. Ahmad A diarrhoeal illness with a difference? BMJ, July 20, 2009; 339(jul20_1): b2648 - b2648. [Full Text]
|
|
|
|
|
|
M. H Wilcox and T. Planche Clostridium difficile infection BMJ, June 23, 2009; 338(jun23_3): b2528 - b2528. [Full Text]
|
|
|
|
|
|
J. Rangaiah, M. Wilks, and M. Millar Community Clostridium difficile BMJ, June 3, 2009; 338(jun02_1): b2195 - b2195. [Full Text]
|
|
|
|
|
|
S E Noblett, M Welfare, and K Seymour The role of surgery in Clostridium difficile colitis BMJ, May 6, 2009; 338(may06_1): b1563 - b1563. [Full Text]
|
|
|
|
 |
|
 S. Dial MD MSc and S. Suissa PhD Use administrative databases with caution Can. Med. Assoc. J., January 6, 2009; 180(1): 78 - 79. [Full Text] [PDF]
|
|
|
|
|
|
E. J. Kuijper MD PhD and J. T. van Dissel MD PhD Spectrum of Clostridium difficile infections outside health care facilities Can. Med. Assoc. J., October 7, 2008; 179(8): 747 - 748. [Full Text] [PDF]
|
|
|
|
|
|
S. Dial MD MSc, A. Kezouh PhD, A. Dascal MD, A. Barkun MD MSc, and S. Suissa PhD Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection Can. Med. Assoc. J., October 7, 2008; 179(8): 767 - 772. [Abstract] [Full Text] [PDF]
|
|